Executive Team

Jonathan Smith, Ph.D.

Executive Vice President & Chief Scientific Officer

Dr. Smith is a pioneer in the development of novel vaccines and vaccine vector systems derived from RNA viruses with more than 25 years of experience in virology, infectious diseases, immunology, and vaccine development. He joined PaxVax from Liquidia, where he was the company’s Chief Scientific Officer, responsible for overseeing research and development programs applying the company’s novel nanoparticle technology to vaccines and other applications. Prior to joining Liquidia in 2010, Dr. Smith was a co-founder and Chief Scientific Officer of AlphaVax, a biotechnology company focused on developing RNA replicon vaccines for infectious diseases, biodefense, and cancer. Prior to his 10 years at AlphaVax, Dr. Smith was a faculty member in the Department of Microbiology at the University of Maryland Medical School and Chief of Viral Biology at the United States Army Medical Research Institute of Infectious Diseases. Dr. Smith received his B.A. from Colby College and his Ph.D. in microbiology/virology from the University of Texas at Austin.